TY  - GEN 
AU  - Sancho, J.-M.
AU  - Marín-Niebla, A.
AU  - Fernández, S.
AU  - Capote, F.-J.
AU  - Cañigral, C.
AU  - Grande, C.
AU  - Donato, E.
AU  - Zeberio, I.
AU  - Puerta, J.-M.
AU  - Rivas, A.
AU  - Pérez-Ceballos, E.
AU  - VALE LOPEZ, ANA MARIA
AU  - Martín García-Sancho, A.
AU  - Salar, A.
AU  - González-Barca, E.
AU  - Teruel, A.
AU  - Pastoriza, C.
AU  - Conde-Royo, D.
AU  - Sánchez-García, J.
AU  - Barrenetxea, C.
AU  - Arranz, R.
AU  - Hernández-Rivas, J.-Á.
AU  - Ramírez, M.-J.
AU  - Jiménez, A.
AU  - Rubio-Azpeitia, E.
PY  - 2022
SN  - 1865-3774
UR  - http://hdl.handle.net/20.500.11940/20509
AB  - This retrospective study evaluated 66 patients diagnosed with relapsed and/or refractory mantle cell lymphoma (R/R MCL) treated with ibrutinib in Spain in routine clinical practice. At diagnosis, patients had a median age of 64.5 years, 63.6%...
LA  - eng
TI  - IBRORS-MCL study: a Spanish retrospective and observational study of relapsed/refractory mantle-cell lymphoma treated with ibrutinib in routine clinical practice
DO  - 10.1007/s12185-022-03367-z
KW  - CHUAC
KW  - AS Coruña
KW  - INIBIC
VL  - 116
ER  -